MicroRNA schizophrenia: Etiology, biomarkers and therapeutic targets

Abdolmaleky, 2014, DNA hypermethylation of serotonin transporter gene promoter in drug naïve patients with schizophrenia, Schizophr. Res, 152, 373, 10.1016/j.schres.2013.12.007 Abi-Dargham, 2014, Schizophrenia: overview and dopamine dysfunction, J. Clin. Psychiatry, 75, 10.4088/JCP.13078tx2c Abi-Dargham, 1999, No evidence of altered in vivo benzodiazepine receptor binding in schizophrenia, Neuropsychopharmacology, 20, 650, 10.1016/S0893-133X(98)00107-9 Abrantes, 2022, Gene expression changes following chronic antipsychotic exposure in single cells from mouse striatum, Mol. Psychiatry, 10.1038/s41380-022-01509-7 ACNP 58th Annual Meeting, 2019, Poster Session I, Neuropsychopharmacology, 44, 78, 10.1038/s41386-019-0545-y Akkouh, 2021, Transcriptome analysis reveals disparate expression of inflammation-related miRNAs and their gene targets in iPSC-astrocytes from people with schizophrenia, Brain Behav. Immun., 94, 235, 10.1016/j.bbi.2021.01.037 Akyol, 2005, Association between Ala-9Val polymorphism of Mn-SOD gene and schizophrenia, Prog. Neuropsychopharmacol. Biol. Psychiatry, 29, 123, 10.1016/j.pnpbp.2004.10.014 Al-Dujaili, 2021, High Mobility Group Protein 1 and Dickkopf-Related Protein 1 in Schizophrenia and Treatment-Resistant Schizophrenia: Associations With Interleukin-6, Symptom Domains, and Neurocognitive Impairments, Schizophr. Bull., 47, 530, 10.1093/schbul/sbaa136 Alexander, 2021, The anterior cingulate cortex as a key locus of ketamine’s antidepressant action, Neurosci. Biobehav Rev., 127, 531, 10.1016/j.neubiorev.2021.05.003 Amoah, 2020, Exosomal secretion of a psychosis-altered miRNA that regulates glutamate receptor expression is affected by antipsychotics, Neuropsychopharmacology, 45, 656, 10.1038/s41386-019-0579-1 Aparecida Nedel Pertile, 2022, Developmental vitamin D-deficiency increases the expression of microRNAs involved in dopamine neuron development, Brain Res, 1789, 10.1016/j.brainres.2022.147953 Arjona, 2007, Abrogation of macrophage migration inhibitory factor decreases West Nile virus lethality by limiting viral neuroinvasion, J. Clin. Invest, 117, 3059, 10.1172/JCI32218 Arshad, 2017, MicroRNAs and Target Genes As Biomarkers for the Diagnosis of Early Onset of Parkinson Disease, Front Mol. Neurosci., 10, 352, 10.3389/fnmol.2017.00352 Bahi, 2018, Lentiviral-mediated let-7d microRNA overexpression induced anxiolytic- and anti-depressant-like behaviors and impaired dopamine D3 receptor expression, Eur. Neuropsychopharmacol., 28, 1394, 10.1016/j.euroneuro.2018.09.004 Bahi, 2020, Lentiviral-mediated up-regulation of let-7d microRNA decreases alcohol intake through down-regulating the dopamine D3 receptor, Eur. Neuropsychopharmacol., 37, 70, 10.1016/j.euroneuro.2020.06.011 Banerjee, 2015, Src kinase as a mediator of convergent molecular abnormalities leading to NMDAR hypoactivity in schizophrenia, Mol. Psychiatry, 20, 1091, 10.1038/mp.2014.115 Bani-Fatemi, 2016, Interaction between Methylation and CpG Single-Nucleotide Polymorphisms in the HTR2A Gene: Association Analysis with Suicide Attempt in Schizophrenia, Neuropsychobiology, 73, 10, 10.1159/000441191 Banigan, 2013, Differential Expression of Exosomal microRNAs in Prefrontal Cortices of Schizophrenia and Bipolar Disorder Patients, PLoS ONE, 8, 10.1371/journal.pone.0048814 Berke, 2018, What does dopamine mean?, Nat. Neurosci., 21, 787, 10.1038/s41593-018-0152-y Berthoux, 2020, Early 5-HT6 receptor blockade prevents symptom onset in a model of adolescent cannabis abuse, EMBO Mol. Med, 12, 10.15252/emmm.201910605 Bertolino, 2009, Functional variants of the dopamine receptor D2 gene modulate prefronto-striatal phenotypes in schizophrenia, Brain, 132, 417, 10.1093/brain/awn248 Beveridge, 2012, MicroRNA dysregulation in schizophrenia, Neurobiol. Dis., 46, 263, 10.1016/j.nbd.2011.12.029 Beveridge, 2008, Dysregulation of miRNA 181b in the temporal cortex in schizophrenia, Hum. Mol. Genet, 17, 1156, 10.1093/hmg/ddn005 Blasi, 2013, Converging evidence for the association of functional genetic variation in the serotonin receptor 2a gene with prefrontal function and olanzapine treatment, JAMA Psychiatry, 70, 921, 10.1001/jamapsychiatry.2013.1378 Boerrigter, 2017, Using blood cytokine measures to define high inflammatory biotype of schizophrenia and schizoaffective disorder, J. Neuroinflamm., 14, 188, 10.1186/s12974-017-0962-y Borelli, 2019, Schizophrenia, JAMA, 322, 1322, 10.1001/jama.2019.11073 Breier, 1997, Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method, Proc. Natl. Acad. Sci. USA, 94, 2569, 10.1073/pnas.94.6.2569 Bressan, 2005, Impact of schizophrenia and chronic antipsychotic treatment on [123I]CNS-1261 binding to N-methyl-D-aspartate receptors in vivo, Biol. Psychiatry, 58, 41, 10.1016/j.biopsych.2005.03.016 Busatto, 1997, Correlation between reduced in vivo benzodiazepine receptor binding and severity of psychotic symptoms in schizophrenia, Am. J. Psychiatry, 154, 56 C, 2014, What causes aberrant salience in schizophrenia? A role for impaired short-term habituation and the GRIA1 (GluA1) AMPA receptor subunit, Mol. Psychiatry, 19 Cai, 2020, Increased macrophages and changed brain endothelial cell gene expression in the frontal cortex of people with schizophrenia displaying inflammation, Mol. Psychiatry, 25, 761, 10.1038/s41380-018-0235-x Çakici, 2019, An update on the efficacy of anti-inflammatory agents for patients with schizophrenia: a meta-analysis, Psychol. Med, 49, 2307, 10.1017/S0033291719001995 Cheleschi, 2019, MicroRNA-34a and MicroRNA-181a Mediate Visfatin-Induced Apoptosis and Oxidative Stress via NF-κB Pathway in Human Osteoarthritic Chondrocytes, Cells, 8, 874, 10.3390/cells8080874 Chen, 2016, A preliminary analysis of microRNA-21 expression alteration after antipsychotic treatment in patients with schizophrenia, Psychiatry Res, 244, 324, 10.1016/j.psychres.2016.04.087 Chen, 2017, Abnormal Concentration of GABA and Glutamate in The Prefrontal Cortex in Schizophrenia.-An in Vivo 1H-MRS Study, Shanghai Arch. Psychiatry, 29, 277 Chen, 2013, The microRNA-148/152 family: multi-faceted players, Mol. Cancer, 12, 43, 10.1186/1476-4598-12-43 Cheng, 2020, Exosomal noncoding RNAs in Glioma: biological functions and potential clinical applications, Mol. Cancer, 19, 66, 10.1186/s12943-020-01189-3 Cheng, 2018, Partial loss of psychiatric risk gene miR-137 in mice causes repetitive behavior and impairs sociability and learning via increased Pde10a, Nat. Neurosci., 21, 1689, 10.1038/s41593-018-0261-7 Chien, 2020, Clinical implications of oxidative stress in schizophrenia: Acute relapse and chronic stable phase, Prog. Neuropsychopharmacol. Biol. Psychiatry, 99, 10.1016/j.pnpbp.2020.109868 Chipman, 2019, miRNA targeting: growing beyond the seed, Trends Genet, 35, 215, 10.1016/j.tig.2018.12.005 Chittiprol, 2010, Oxidative stress and neopterin abnormalities in schizophrenia: a longitudinal study, J. Psychiatr. Res, 44, 310, 10.1016/j.jpsychires.2009.09.002 Cho, 2019, Adjunctive use of anti-inflammatory drugs for schizophrenia: A meta-analytic investigation of randomized controlled trials, Aust. N. Z. J. Psychiatry, 53, 742, 10.1177/0004867419835028 Chowdari, 2011, Genetic association studies of antioxidant pathway genes and schizophrenia, Antioxid. Redox Signal, 15, 2037, 10.1089/ars.2010.3508 Chun, 2014, Specific disruption of thalamic inputs to the auditory cortex in schizophrenia models, Science, 344, 1178, 10.1126/science.1253895 Chun, 2017, Thalamic miR-338-3p mediates auditory thalamocortical disruption and its late onset in models of 22q11.2 microdeletion, Nat. Med, 23, 39, 10.1038/nm.4240 Correll, 2020, Efficacy and Safety of Lumateperone for Treatment of Schizophrenia: A Randomized Clinical Trial, JAMA Psychiatry, 77, 349, 10.1001/jamapsychiatry.2019.4379 Coughlin, 2021, A multimodal approach to studying the relationship between peripheral glutathione, brain glutamate, and cognition in health and in schizophrenia, Mol. Psychiatry, 26, 3502, 10.1038/s41380-020-00901-5 D, 2021, miR-936 is Increased in Schizophrenia and Inhibits Neural Development and AMPA Receptor-Mediated Synaptic Transmission, Schizophr. Bull., 47 Da Silva, 2019, GABA levels and TSPO expression in people at clinical high risk for psychosis and healthy volunteers: a PET-MRS study, J. Psychiatry Neurosci., 44, 111, 10.1503/jpn.170201 Das, 2019, Antioxidant defense in schizophrenia and bipolar disorder: A meta-analysis of MRS studies of anterior cingulate glutathione, Prog. Neuropsychopharmacol. Biol. Psychiatry, 91, 94, 10.1016/j.pnpbp.2018.08.006 Davarinejad, 2022, MiR-574–5 P, miR-1827, and miR-4429 as Potential Biomarkers for Schizophrenia, J. Mol. Neurosci., 72, 226, 10.1007/s12031-021-01945-0 De Lazzari, 2021, DJ-1: A promising therapeutic candidate for ischemia-reperfusion injury, Redox Biol., 41, 10.1016/j.redox.2021.101884 van den Buuse, 2018, Interaction of Brain-Derived Neurotrophic Factor Val66Met genotype and history of stress in regulation of prepulse inhibition in mice, Schizophr. Res, 198, 60, 10.1016/j.schres.2017.08.019 Di Matteo, 2001, Role of 5-HT(2C) receptors in the control of central dopamine function, Trends Pharm. Sci., 22, 229, 10.1016/S0165-6147(00)01688-6 Dong, 2013, MicroRNA: function, detection, and bioanalysis, Chem. Rev., 113, 6207, 10.1021/cr300362f Downey, 2016, Comparing the actions of lanicemine and ketamine in depression: key role of the anterior cingulate, Eur. Neuropsychopharmacol., 26, 994, 10.1016/j.euroneuro.2016.03.006 Dracheva, 2004, GAD67 and GAD65 mRNA and protein expression in cerebrocortical regions of elderly patients with schizophrenia, J. Neurosci. Res, 76, 581, 10.1002/jnr.20122 Du, 2019, Genome-wide, integrative analysis implicates exosome-derived MicroRNA dysregulation in schizophrenia, Schizophr. Bull., 45, 1257, 10.1093/schbul/sby191 Du, 2020, A network analysis of epigenetic and transcriptional regulation in a neurodevelopmental rat model of schizophrenia with implications for translational research, Schizophr. Bull., 46, 612, 10.1093/schbul/sbz114 Du, 2021, Metabolomic identification of exosome-derived biomarkers for schizophrenia: a large multicenter study, Schizophr. Bull., 47, 615, 10.1093/schbul/sbaa166 Du, 2021, Exosome transplantation from patients with schizophrenia causes schizophrenia-relevant behaviors in mice: an integrative multi-omics data analysis, Schizophr. Bull., 47, 1288, 10.1093/schbul/sbab039 Duman, 2019, Altered connectivity in depression: GABA and glutamate neurotransmitter deficits and reversal by novel treatments, Neuron, 102, 75, 10.1016/j.neuron.2019.03.013 Dwir, 2020, MMP9/RAGE pathway overactivation mediates redox dysregulation and neuroinflammation, leading to inhibitory/excitatory imbalance: a reverse translation study in schizophrenia patients, Mol. Psychiatry, 25, 2889, 10.1038/s41380-019-0393-5 Egan, 2003, The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function, Cell, 112, 257, 10.1016/S0092-8674(03)00035-7 Egerton, 2017, Neuroimaging studies of GABA in schizophrenia: a systematic review with meta-analysis, Transl. Psychiatry, 7, 10.1038/tp.2017.124 Elmén, 2008, LNA-mediated microRNA silencing in non-human primates, Nature, 452, 896, 10.1038/nature06783 Emiliani, 2014, Oxidative stress and schizophrenia: recent breakthroughs from an old story, Curr. Opin. Psychiatry, 27, 185, 10.1097/YCO.0000000000000054 van Erp, 2014, Schizophrenia miR-137 Locus Risk Genotype is Associated with DLPFC Hyperactivation, Biol. Psychiatry, 75, 398, 10.1016/j.biopsych.2013.06.016 Escudero-Esparza, 2013, The novel complement inhibitor human CUB and Sushi multiple domains 1 (CSMD1) protein promotes factor I-mediated degradation of C4b and C3b and inhibits the membrane attack complex assembly, FASEB J., 27, 5083, 10.1096/fj.13-230706 Fan, 2015, Altered microRNA Expression in Peripheral Blood Mononuclear Cells from Young Patients with Schizophrenia, J. Mol. Neurosci., 56, 562, 10.1007/s12031-015-0503-z Fernandes, 2015, Peripheral brain-derived neurotrophic factor in schizophrenia and the role of antipsychotics: meta-analysis and implications, Mol. Psychiatry, 20, 1108, 10.1038/mp.2014.117 Finkel, 2016, Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study, Lancet, 388, 3017, 10.1016/S0140-6736(16)31408-8 Fraguas, 2019, Oxidative Stress and Inflammation in First-Episode Psychosis: A Systematic Review and Meta-analysis, Schizophr. Bull., 45, 742, 10.1093/schbul/sby125 Fu, 2022, Deregulatory miRNA-BDNF network inferred from dynamic expression changes in schizophrenia, Brain Sci., 12, 167, 10.3390/brainsci12020167 Fujigaki, 2019, Linking phencyclidine intoxication to the tryptophan-kynurenine pathway: Therapeutic implications for schizophrenia, Neurochem Int, 125, 1, 10.1016/j.neuint.2019.02.001 Fulcher, 2020, Deciphering midbrain mechanisms underlying prepulse inhibition of startle, Prog. Neurobiol., 185, 10.1016/j.pneurobio.2019.101734 Gao, 2020, Co-delivery of resolvin D1 and antibiotics with nanovesicles to lungs resolves inflammation and clears bacteria in mice, Commun. Biol., 3, 680, 10.1038/s42003-020-01410-5 Gawryluk, 2011, Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders, Int J. Neuropsychopharmacol., 14, 123, 10.1017/S1461145710000805 Ghadirivasfi, 2011, Hypomethylation of the serotonin receptor type-2A Gene (HTR2A) at T102C polymorphic site in DNA derived from the saliva of patients with schizophrenia and bipolar disorder, Am. J. Med Genet B Neuropsychiatr. Genet, 156B, 536, 10.1002/ajmg.b.31192 Ghamari, 2022, Serotonin transporter functional polymorphisms potentially increase risk of schizophrenia separately and as a haplotype, Sci. Rep., 12, 1336, 10.1038/s41598-022-05206-x Goh, 2019, Role of MicroRNAs in Parkinson’s Disease, Int J. Mol. Sci., 20, 10.3390/ijms20225649 Gong, 2013, Polymorphisms in microRNA target sites influence susceptibility to schizophrenia by altering the binding of miRNAs to their targets, Eur. Neuropsychopharmacol., 23, 1182, 10.1016/j.euroneuro.2012.12.002 Gonzalez-Liencres, 2014, Oxidative stress in schizophrenia: a case-control study on the effects on social cognition and neurocognition, BMC Psychiatry, 14, 268, 10.1186/s12888-014-0268-x González-Maeso, 2009, Psychedelics and schizophrenia, Trends Neurosci., 32, 225, 10.1016/j.tins.2008.12.005 Gorinski, 2019, Attenuated palmitoylation of serotonin receptor 5-HT1A affects receptor function and contributes to depression-like behaviors, Nat. Commun., 10, 3924, 10.1038/s41467-019-11876-5 Greening, 2021, Chronic methamphetamine interacts with BDNF Val66Met to remodel psychosis pathways in the mesocorticolimbic proteome, Mol. Psychiatry, 26, 4431, 10.1038/s41380-019-0617-8 Gregory, 2005, Human RISC couples microRNA biogenesis and posttranscriptional gene silencing, Cell, 123, 631, 10.1016/j.cell.2005.10.022 Gunasekaran, 2022, Differential expression of miR-148b, miR-129-2 and miR-296 in animal models of schizophrenia-Relevance to NMDA receptor hypofunction, Neuropharmacology, 210, 10.1016/j.neuropharm.2022.109024 Gysin, 2007, Impaired glutathione synthesis in schizophrenia: convergent genetic and functional evidence, Proc. Natl. Acad. Sci. USA, 104, 16621, 10.1073/pnas.0706778104 Hafizi, 2018, Interaction between TSPO—a neuroimmune marker—and redox status in clinical high risk for psychosis: a PET–MRS study, Neuropsychopharmacology, 43, 1700, 10.1038/s41386-018-0061-5 Hamid, 2016, Mesolimbic Dopamine Signals the Value of Work, Nat. Neurosci., 19, 117, 10.1038/nn.4173 Hammond, 2015, An overview of microRNAs, Adv. Drug Deliv. Rev., 87, 3, 10.1016/j.addr.2015.05.001 Harb, 2021, BDNF haploinsufficiency induces behavioral endophenotypes of schizophrenia in male mice that are rescued by enriched environment, Transl. Psychiatry, 11, 233, 10.1038/s41398-021-01365-z Hashimoto, 2008, Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia, Mol. Psychiatry, 13, 147, 10.1038/sj.mp.4002011 Hayes, 2014, MicroRNAs in cancer: biomarkers, functions and therapy, Trends Mol. Med, 20, 460, 10.1016/j.molmed.2014.06.005 He, 2018, MiRNAs of peripheral blood as the biomarker of schizophrenia, Hereditas, 155, 9, 10.1186/s41065-017-0044-2 Hermance, 2019, Ixodes scapularis salivary gland microRNAs are differentially expressed during Powassan virus transmission, Sci. Rep., 9, 13110, 10.1038/s41598-019-49572-5 Holbrook, 2009, Characterisation of 5-HT3C, 5-HT3D and 5-HT3E receptor subunits: evolution, distribution and function, J. Neurochem., 108, 384, 10.1111/j.1471-4159.2008.05775.x Holcomb, 2005, Effects of noncompetitive NMDA receptor blockade on anterior cingulate cerebral blood flow in volunteers with schizophrenia, Neuropsychopharmacology, 30, 2275, 10.1038/sj.npp.1300824 Hori, 2000, Manganese superoxide dismutase gene polymorphism and schizophrenia: relation to tardive dyskinesia, Neuropsychopharmacology, 23, 170, 10.1016/S0893-133X(99)00156-6 Hou, 2018, Schizophrenia-associated rs4702 G allele-specific downregulation of FURIN expression by miR-338-3p reduces BDNF production, Schizophr. Res, 199, 176, 10.1016/j.schres.2018.02.040 Howes, 2009, The dopamine hypothesis of schizophrenia: version III--the final common pathway, Schizophr. Bull., 35, 549, 10.1093/schbul/sbp006 Howes, 2013, Midbrain dopamine function in schizophrenia and depression: a post-mortem and positron emission tomographic imaging study, Brain, 136, 3242, 10.1093/brain/awt264 Hu, 2019, Electro-acupuncture-induced neuroprotection is associated with activation of the IGF-1/PI3K/Akt pathway following adjacent dorsal root ganglionectomies in rats, Int J. Mol. Med, 43, 807 Hu, 2019, Temporal dynamics of miRNAs in human DLPFC and its association with miRNA dysregulation in schizophrenia, Transl. Psychiatry, 9, 196, 10.1038/s41398-019-0538-y Huang, 2018, 5-HT1A parital agonism and 5-HT7 antagonism restore episodic memory in subchronic phencyclidine-treated mice: role of brain glutamate, dopamine, acetylcholine and GABA, Psychopharmacol. (Berl. ), 235, 2795, 10.1007/s00213-018-4972-y Huppke, 2017, Activating de novo mutations in NFE2L2 encoding NRF2 cause a multisystem disorder, Nat. Commun., 8, 818, 10.1038/s41467-017-00932-7 Ibrahim, 2020, Micro RNA 146a gene variant / TNF-α / IL-6 / IL-1 β; A cross-link axis inbetween oxidative stress, endothelial dysfunction and neuro-inflammation in acute ischemic stroke and chronic schizophrenic patients, Arch. Biochem Biophys., 679, 10.1016/j.abb.2019.108193 Idda, 2018, Noncoding RNAs in Alzheimer’s disease, Wiley Inter. Rev. RNA, 9 Ikegame, 2020, Promoter Activity-Based Case-Control Association Study on SLC6A4 Highlighting Hypermethylation and Altered Amygdala Volume in Male Patients With Schizophrenia, Schizophr. Bull., 46, 1577, 10.1093/schbul/sbaa075 Jackson, 2020, Meta-analysis of total and differential white blood cell counts in schizophrenia, Acta Psychiatr. Scand., 142, 18, 10.1111/acps.13140 Jacob, 2008, GABA(A) receptor trafficking and its role in the dynamic modulation of neuronal inhibition, Nat. Rev. Neurosci., 9, 331, 10.1038/nrn2370 Jauhar, 2022, Schizophrenia, Lancet, 399, 473, 10.1016/S0140-6736(21)01730-X Jayawickrama, 2015, Kynurenine Aminotransferases and the Prospects of Inhibitors for the Treatment of Schizophrenia, Curr. Med Chem., 22, 2902, 10.2174/0929867322666150608094054 Jin, 2022, Identification of Peripheral Blood miRNA Biomarkers in First-Episode Drug-Free Schizophrenia Patients Using Bioinformatics Strategy, Mol. Neurobiol., 59, 4730, 10.1007/s12035-022-02878-4 Jones, 2020, Emerging 5-HT receptor antagonists for the treatment of Schizophrenia, Expert Opin. Emerg. Drugs, 25, 189, 10.1080/14728214.2020.1773792 Kaalund, 2014, Contrasting changes in DRD1 and DRD2 splice variant expression in schizophrenia and affective disorders, and associations with SNPs in postmortem brain, Mol. Psychiatry, 19, 1258, 10.1038/mp.2013.165 Kahn, 2020, On the Origins of Schizophrenia, Am. J. Psychiatry, 177, 291, 10.1176/appi.ajp.2020.20020147 Kataruka, 2020, MicroRNA dilution during oocyte growth disables the microRNA pathway in mammalian oocytes, Nucleic Acids Res, 48, 8050, 10.1093/nar/gkaa543 Katthagen, 2020, Striatal Dopamine and Reward Prediction Error Signaling in Unmedicated Schizophrenia Patients, Schizophr. Bull., 46, 1535, 10.1093/schbul/sbaa055 Khadimallah, 2022, Mitochondrial, exosomal miR137-COX6A2 and gamma synchrony as biomarkers of parvalbumin interneurons, psychopathology, and neurocognition in schizophrenia, Mol. Psychiatry, 27, 1192, 10.1038/s41380-021-01313-9 Kim, 2021, Association Between Lack of Insight and Prefrontal Serotonin Transporter Availability in Antipsychotic-Free Patients with Schizophrenia: A High-Resolution PET Study with [11C]DASB, Neuropsychiatr. Dis. Treat., 17, 3195, 10.2147/NDT.S336126 Kim, 2016, Transcriptome sequencing of the choroid plexus in schizophrenia, Transl. Psychiatry, 6, 10.1038/tp.2016.229 Kim, 2017, Redox Dysregulation in Schizophrenia Revealed by in vivo NAD+/NADH Measurement, Schizophr. Bull., 43, 197, 10.1093/schbul/sbw129 Kim, 2004, MicroRNA precursors in motion: exportin-5 mediates their nuclear export, Trends Cell Biol., 14, 156, 10.1016/j.tcb.2004.02.006 Kirkpatrick, 2013, Inflammation and schizophrenia, Schizophr. Bull., 39, 1174, 10.1093/schbul/sbt141 Kocerha, 2009, MicroRNA-219 modulates NMDA receptor-mediated neurobehavioral dysfunction, Proc. Natl. Acad. Sci. USA, 106, 3507, 10.1073/pnas.0805854106 Konradi, 2003, Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment, Pharm. Ther., 97, 153, 10.1016/S0163-7258(02)00328-5 Kos, 2016, Exome sequence data from multigenerational families implicate AMPA receptor trafficking in neurocognitive impairment and schizophrenia risk, Schizophr. Bull., 42, 288, 10.1093/schbul/sbv135 Krol, 2010, The widespread regulation of microRNA biogenesis, function and decay, Nat. Rev. Genet, 11, 597, 10.1038/nrg2843 Krystal, 1994, Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses, Arch. Gen. Psychiatry, 51, 199, 10.1001/archpsyc.1994.03950030035004 Kulak, 2013, Redox dysregulation in the pathophysiology of schizophrenia and bipolar disorder: insights from animal models, Antioxid. Redox Signal, 18, 1428, 10.1089/ars.2012.4858 Kumar, 2020, Glutathione and glutamate in schizophrenia: a 7T MRS study, Mol. Psychiatry, 25, 873, 10.1038/s41380-018-0104-7 Kumar, 2021, Frontal GABA in schizophrenia: A meta-analysis of 1H-MRS studies, World J. Biol. Psychiatry, 22, 1, 10.1080/15622975.2020.1731925 Kunii, 2014, Revisiting DARPP-32 in postmortem human brain: changes in schizophrenia and bipolar disorder and genetic associations with t-DARPP-32 expression, Mol. Psychiatry, 19, 192, 10.1038/mp.2012.174 Lähteenvuo, 2021, Antipsychotic polypharmacy for the management of schizophrenia: evidence and recommendations, Drugs, 81, 1273, 10.1007/s40265-021-01556-4 Lai, 2011, MicroRNA expression aberration as potential peripheral blood biomarkers for schizophrenia, PLoS One, 6, 10.1371/journal.pone.0021635 Lanz, 2019, Transl. Psychiatry, 9, 151, 10.1038/s41398-019-0492-8 Laruelle, 2000, Dopamine and serotonin transporters in patients with schizophrenia: an imaging study with [(123)I]beta-CIT, Biol. Psychiatry, 47, 371, 10.1016/S0006-3223(99)00257-7 Lau, 2013, Does the dopamine hypothesis explain schizophrenia, Rev. Neurosci., 24, 389, 10.1515/revneuro-2013-0011 Lee, 2019, The regulation of glutamic acid decarboxylases in GABA neurotransmission in the brain, Arch. Pharm. Res, 42, 1031, 10.1007/s12272-019-01196-z Lee, 2012, miR-206 regulates brain-derived neurotrophic factor in Alzheimer disease model, Ann. Neurol., 72, 269, 10.1002/ana.23588 Letellier, 2014, miR-92a regulates expression of synaptic GluA1-containing AMPA receptors during homeostatic scaling, Nat. Neurosci., 17, 1040, 10.1038/nn.3762 Lewis, 2012, Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia, Trends Neurosci., 35, 57, 10.1016/j.tins.2011.10.004 Lewis, 1999, Serotonin 5-HT2 receptors in schizophrenia: a PET study using [18F]setoperone in neuroleptic-naive patients and normal subjects, Am. J. Psychiatry, 156, 72, 10.1176/ajp.156.1.72 Li, 2008, Dispatched Homolog 2 is targeted by miR-214 through a combination of three weak microRNA recognition sites, Nucleic Acids Res, 36, 4277, 10.1093/nar/gkn388 Li, 2013, Association of serotonin transporter gene (SLC6A4) polymorphisms with schizophrenia susceptibility and symptoms in a Chinese-Han population, Prog. Neuropsychopharmacol. Biol. Psychiatry, 44, 290, 10.1016/j.pnpbp.2013.04.003 Liang, 2022, Membrane-decorated exosomes for combination drug delivery and improved glioma therapy, Langmuir, 38, 299, 10.1021/acs.langmuir.1c02500 Liang, W., Hou, Y., Huang, W., Wang, Y., Jiang, T., Huang, X., Wang, Z., Wu, F., Zheng, J., Zhang, Jie, Ou, H., Li, Shuyun, Ping, J., Zhang, Y., Ye, J., Li, Z., Yang, Q., Zhang, Jian, Zheng, X., Li, Shufen, Zhu, X.-H., Chen, R., Zhao, C., n.d. Loss of schizophrenia-related miR-501–3p in mice impairs sociability and memory by enhancing mGluR5-mediated glutamatergic transmission. Sci Adv 8, eabn7357. https://doi.org/10.1126/sciadv.abn7357. Ligthart, 2018, Genome Analyses of >200,000 Individuals Identify 58 Loci for Chronic Inflammation and Highlight Pathways that Link Inflammation and Complex Disorders, 103, 691 Lin, 2015, MicroRNA biogenesis pathways in cancer, Nat. Rev. Cancer, 15, 321, 10.1038/nrc3932 Liu, 2017, The early growth response protein 1-miR-30a-5p-neurogenic differentiation factor 1 axis as a novel biomarker for schizophrenia diagnosis and treatment monitoring, Transl. Psychiatry, 7, 10.1038/tp.2016.268 Liu, 2017, Diagnostic value of blood-derived microRNAs for schizophrenia: results of a meta-analysis and validation, Sci. Rep., 7, 15328, 10.1038/s41598-017-15751-5 Liu, 2020, Charge conversional biomimetic nanocomplexes as a multifunctional platform for boosting orthotopic glioblastoma RNAi therapy, Nano Lett., 20, 1637, 10.1021/acs.nanolett.9b04683 López-Giménez, 2018, Hallucinogens and Serotonin 5-HT2A Receptor-Mediated Signaling Pathways, Curr. Top. Behav. Neurosci., 36, 45, 10.1007/7854_2017_478 Ma, 2018, Identification of miR-22-3p, miR-92a-3p, and miR-137 in peripheral blood as biomarker for schizophrenia, Psychiatry Res, 265, 70, 10.1016/j.psychres.2018.03.080 Ma, 2016, Impaired GABA synthesis, uptake and release are associated with depression-like behaviors induced by chronic mild stress, Transl. Psychiatry, 6, 10.1038/tp.2016.181 Ma, 2019, The molecular mechanism underlying GABAergic dysfunction in nucleus accumbens of depression-like behaviours in mice, J. Cell Mol. Med, 23, 7021, 10.1111/jcmm.14596 Magen, 2021, Circulating miR-181 is a prognostic biomarker for amyotrophic lateral sclerosis, Nat. Neurosci., 24, 1534, 10.1038/s41593-021-00936-z Mansoori, 2020, Hyaluronic acid-decorated liposomal nanoparticles for targeted delivery of 5-fluorouracil into HT-29 colorectal cancer cells, J. Cell Physiol., 235, 6817, 10.1002/jcp.29576 Marder, 2019, Schizophrenia, N. Engl. J. Med, 381, 1753, 10.1056/NEJMra1808803 Marsman, 2013, Glutamate in schizophrenia: a focused review and meta-analysis of 1H-MRS studies, Schizophr. Bull., 39, 120, 10.1093/schbul/sbr069 Matsuzawa, 2011, Magnetic resonance spectroscopy study of the antioxidant defense system in schizophrenia, Antioxid. Redox Signal, 15, 2057, 10.1089/ars.2010.3453 Matsuzawa, 2008, Negative correlation between brain glutathione level and negative symptoms in schizophrenia: a 3T 1H-MRS study, PLoS One, 3, 10.1371/journal.pone.0001944 McCutcheon, 2019, Schizophrenia, Dopamine and the Striatum: From Biology to Symptoms, Trends Neurosci., 42, 205, 10.1016/j.tins.2018.12.004 McCutcheon, 2020, Dopamine and glutamate in schizophrenia: biology, symptoms and treatment, World Psychiatry, 19, 15, 10.1002/wps.20693 McCutcheon, 2020, Schizophrenia-An Overview, JAMA Psychiatry, 77, 201, 10.1001/jamapsychiatry.2019.3360 McGregor, 2017, Estrogens and the cognitive symptoms of schizophrenia: Possible neuroprotective mechanisms, Front Neuroendocr., 47, 19, 10.1016/j.yfrne.2017.06.003 Mei, 2018, Astrocytic regulation of glutamate transmission in schizophrenia, Front Psychiatry, 9, 544, 10.3389/fpsyt.2018.00544 Mellios, 2009, Molecular determinants of dysregulated GABAergic gene expression in the prefrontal cortex of subjects with schizophrenia, Biol. Psychiatry, 65, 1006, 10.1016/j.biopsych.2008.11.019 Miller, 2010, MicroRNA dysregulation in psychiatric disease, Brain Res, 1338, 89, 10.1016/j.brainres.2010.03.035 Miller, 2013, Meta-analysis of lymphocytes in schizophrenia: clinical status and antipsychotic effects, Biol. Psychiatry, 73, 993, 10.1016/j.biopsych.2012.09.007 Miller, 2019, Divergent medial amygdala projections regulate approach-avoidance conflict behavior, Nat. Neurosci., 22, 565, 10.1038/s41593-019-0337-z Missale, 1998, Dopamine Receptors: From Structure to Function, Physiol. Rev., 78, 189, 10.1152/physrev.1998.78.1.189 Mohr, 2015, Overview of microRNA biology, Semin Liver Dis., 35, 3, 10.1055/s-0034-1397344 Morozova, 2019, Association of rs4680 COMT, rs6280 DRD3, and rs7322347 5HT2A With Clinical Features of Youth-Onset Schizophrenia, Front Psychiatry, 10, 830, 10.3389/fpsyt.2019.00830 Murchison, 2004, miRNAs on the move: miRNA biogenesis and the RNAi machinery, Curr. Opin. Cell Biol., 16, 223, 10.1016/j.ceb.2004.04.003 Murray, 2021, Oxidative Stress and the Pathophysiology and Symptom Profile of Schizophrenia Spectrum Disorders, Front Psychiatry, 12, 10.3389/fpsyt.2021.703452 Nakahara, 2022, Glutamatergic and GABAergic metabolite levels in schizophrenia-spectrum disorders: a meta-analysis of 1H-magnetic resonance spectroscopy studies, Mol. Psychiatry, 27, 744, 10.1038/s41380-021-01297-6 Nakazawa, 2020, The origin of NMDA receptor hypofunction in schizophrenia, Pharmacol. Ther., 205, 10.1016/j.pharmthera.2019.107426 Napolitano, 2014, In vivo neurometabolic profiling to characterize the effects of social isolation and ketamine-induced NMDA antagonism: a rodent study at 7.0 T, Schizophr. Bull., 40, 566, 10.1093/schbul/sbt067 Ngan, 2000, Decreased serotonin 2A receptor densities in neuroleptic-naive patients with schizophrenia: A PET study using [(18)F]setoperone, Am. J. Psychiatry, 157, 1016, 10.1176/appi.ajp.157.6.1016 Nieto, 2021, BDNF as a biomarker of cognition in schizophrenia/psychosis: an updated review, Front Psychiatry, 12, 10.3389/fpsyt.2021.662407 Notaras, 2015, A role for the BDNF gene Val66Met polymorphism in schizophrenia? A comprehensive review, Neurosci. Biobehav Rev., 51, 15, 10.1016/j.neubiorev.2014.12.016 Notaras, 2017, BDNF Val66Met Genotype Interacts With a History of Simulated Stress Exposure to Regulate Sensorimotor Gating and Startle Reactivity, Schizophr. Bull., 43, 665 O’Brien, 2018, Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation, Front Endocrinol. (Lausanne), 9, 402, 10.3389/fendo.2018.00402 Oishi, 2021, Genetic risks of schizophrenia identified in a matched case-control study, Eur. Arch. Psychiatry Clin. Neurosci., 271, 775, 10.1007/s00406-020-01158-3 Okubo, 1997, Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET, Nature, 385, 634, 10.1038/385634a0 Orlovska-Waast, 2019, Cerebrospinal fluid markers of inflammation and infections in schizophrenia and affective disorders: a systematic review and meta-analysis, Mol. Psychiatry, 24, 869, 10.1038/s41380-018-0220-4 Orsolini, 2018, Protein-C Reactive as Biomarker Predictor of Schizophrenia Phases of Illness? A Systematic Review, Curr. Neuropharmacol., 16, 583, 10.2174/1570159X16666180119144538 Owen, 2016, Schizophrenia, Lancet, 388, 86, 10.1016/S0140-6736(15)01121-6 Pan, 2021, The microRNA-195 - BDNF pathway and cognitive deficits in schizophrenia patients with minimal antipsychotic medication exposure, Transl. Psychiatry, 11, 117, 10.1038/s41398-021-01240-x Panganiban, 2020, A Zika virus primary isolate induces neuroinflammation, compromises the blood‐brain barrier and upregulates CXCL12 in adult macaques, Brain Pathol., 30, 1017, 10.1111/bpa.12873 Pascale, 2020, Noncoding RNAs and Midbrain DA Neurons: Novel Molecular Mechanisms and Therapeutic Targets in Health and Disease, Biomolecules, 10, 10.3390/biom10091269 Paul, 2018, Interplay between miRNAs and human diseases, J. Cell Physiol., 233, 2007, 10.1002/jcp.25854 Peitl, 2017, Depressive symptoms in schizophrenia and dopamine and serotonin gene polymorphisms, Prog. Neuropsychopharmacol. Biol. Psychiatry, 77, 209, 10.1016/j.pnpbp.2017.04.011 Perkins, 2007, microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder, Genome Biol., 8, R27, 10.1186/gb-2007-8-2-r27 Perry, 2021, The potential shared role of inflammation in insulin resistance and schizophrenia: A bidirectional two-sample mendelian randomization study, PLoS Med, 18, 10.1371/journal.pmed.1003455 Petryshen, 2010, Population genetic study of the brain-derived neurotrophic factor (BDNF) gene, Mol. Psychiatry, 15, 810, 10.1038/mp.2009.24 Plitman, 2017, Kynurenic acid in schizophrenia: a systematic review and meta-analysis, Schizophr. Bull., 43, 764, 10.1093/schbul/sbw221 Pogorelov, 2017, 5-HT2C agonists modulate schizophrenia-like behaviors in mice, Neuropsychopharmacology, 42, 2163, 10.1038/npp.2017.52 Prata, 2017, Bridging Autism Spectrum Disorders and Schizophrenia through inflammation and biomarkers - pre-clinical and clinical investigations, J. Neuroinflamm., 14, 179, 10.1186/s12974-017-0938-y Preller, 2018, Changes in global and thalamic brain connectivity in LSD-induced altered states of consciousness are attributable to the 5-HT2A receptor, Elife, 7, 10.7554/eLife.35082 Pritchard, 2012, MicroRNA profiling: approaches and considerations, Nat. Rev. Genet, 13, 358, 10.1038/nrg3198 Purves-Tyson, 2017, Putative presynaptic dopamine dysregulation in schizophrenia is supported by molecular evidence from post-mortem human midbrain, Transl. Psychiatry, 7, 10.1038/tp.2016.257 Purves-Tyson, 2021, Reductions in midbrain GABAergic and dopamine neuron markers are linked in schizophrenia, Mol. Brain, 14, 96, 10.1186/s13041-021-00805-7 Qin, 2017, A meta-analysis of peripheral blood nerve growth factor levels in patients with schizophrenia, Mol. Psychiatry, 22, 1306, 10.1038/mp.2016.235 Rajgor, 2020, Local miRNA-Dependent Translational Control of GABAAR Synthesis during Inhibitory Long-Term Potentiation, Cell Rep., 31, 10.1016/j.celrep.2020.107785 Reynolds, 2020, Transmigration of Tetraspanin 2 (Tspan2) siRNA Via Microglia Derived Exosomes across the Blood Brain Barrier Modifies the Production of Immune Mediators by Microglia Cells, J. Neuroimmune Pharm., 15, 554, 10.1007/s11481-019-09895-6 Rizos, 2016, miRNAs and their role in the correlation between schizophrenia and cancer (Review), Mol. Med Rep., 14, 4942, 10.3892/mmr.2016.5853 Robison, 2020, Cognition and reward circuits in schizophrenia: synergistic, not separate, Biol. Psychiatry, 87, 204, 10.1016/j.biopsych.2019.09.021 Rodrigues da Silva, 2020, Cannabidiol attenuates behavioral changes in a rodent model of schizophrenia through 5-HT1A, but not CB1 and CB2 receptors, Pharm. Res, 156, 10.1016/j.phrs.2020.104749 Roth, 2004, Serotonin receptors represent highly favorable molecular targets for cognitive enhancement in schizophrenia and other disorders, Psychopharmacol. (Berl. ), 174, 17, 10.1007/s00213-003-1683-8 Rowland, 2005, Effects of ketamine on anterior cingulate glutamate metabolism in healthy humans: a 4-T proton MRS study, Am. J. Psychiatry, 162, 394, 10.1176/appi.ajp.162.2.394 Rowland, 2013, In vivo measurements of glutamate, GABA, and NAAG in schizophrenia, Schizophr. Bull., 39, 1096, 10.1093/schbul/sbs092 Rowland, 2016, Medial frontal GABA is lower in older schizophrenia: a MEGA-PRESS with macromolecule suppression study, Mol. Psychiatry, 21, 198, 10.1038/mp.2015.34 Santarelli, 2011, Upregulation of dicer and microRNA expression in the dorsolateral prefrontal cortex Brodmann area 46 in schizophrenia, Biol. Psychiatry, 69, 180, 10.1016/j.biopsych.2010.09.030 Schizophrenia Working Group of the Psychiatric Genomics Consortium, 2014, Biological insights from 108 schizophrenia-associated genetic loci, Nature, 511, 421, 10.1038/nature13595 Schmidt, 2019, Acetylsalicylic acid (aspirin) for schizophrenia, Cochrane Database Syst. Rev., 8, CD012116 Seeman, 1984, Bimodal distribution of dopamine receptor densities in brains of schizophrenics, Science, 225, 728, 10.1126/science.6147018 Selvaraj, 2014, Alterations in the serotonin system in schizophrenia: a systematic review and meta-analysis of postmortem and molecular imaging studies, Neurosci. Biobehav Rev., 45, 233, 10.1016/j.neubiorev.2014.06.005 Sherman Horev, 2018, Increase in Processing Factors Is Involved in Skewed MicroRNA Expression in Patients with Ulcerative Colitis Who Develop Small Intestine Inflammation after Pouch Surgery, Inflamm. Bowel Dis., 24, 1045, 10.1093/ibd/izy034 Shi, 2009, Common variants on chromosome 6p22.1 are associated with schizophrenia, Nature, 460, 753, 10.1038/nature08192 Shi, 2014, MicroRNA-9 and microRNA-326 regulate human dopamine D2 receptor expression, and the microRNA-mediated expression regulation is altered by a genetic variant, J. Biol. Chem., 289, 13434, 10.1074/jbc.M113.535203 Shortall, 2018, Characterization of Behavioral, Signaling and Cytokine Alterations in a Rat Neurodevelopmental Model for Schizophrenia, and Their Reversal by the 5-HT6 Receptor Antagonist SB-399885, Mol. Neurobiol., 55, 7413, 10.1007/s12035-018-0940-0 Sommer, 2014, Efficacy of anti-inflammatory agents to improve symptoms in patients with schizophrenia: an update, Schizophr. Bull., 40, 181, 10.1093/schbul/sbt139 Song, 2014, A preliminary analysis of association between the down-regulation of microRNA-181b expression and symptomatology improvement in schizophrenia patients before and after antipsychotic treatment, 54, 134 Song, 2022, Selection of rAAV vectors that cross the human blood-brain barrier and target the central nervous system using a transwell model, Mol. Ther. Methods Clin. Dev., 27, 73, 10.1016/j.omtm.2022.09.002 Stahl, 2018, Beyond the dopamine hypothesis of schizophrenia to three neural networks of psychosis: dopamine, serotonin, and glutamate, CNS Spectr., 23, 187, 10.1017/S1092852918001013 Stan, 2015, Magnetic resonance spectroscopy and tissue protein concentrations together suggest lower glutamate signaling in dentate gyrus in schizophrenia, Mol. Psychiatry, 20, 433, 10.1038/mp.2014.54 Stefansson, 2009, Common variants conferring risk of schizophrenia, 460, 744 Stegeman, 2015, A large scale analysis of genetic variants within putative miRNA binding sites in prostate cancer, Cancer Disco, 5, 368, 10.1158/2159-8290.CD-14-1057 Steinberg, 2019, 5-HT1A receptor, 5-HT2A receptor and serotonin transporter binding in the human auditory cortex in depression, J. Psychiatry Neurosci., 44, 294, 10.1503/jpn.180190 Steiner, 2016, GABAergic system impairment in the hippocampus and superior temporal gyrus of patients with paranoid schizophrenia: A post-mortem study, Schizophr. Res, 177, 10, 10.1016/j.schres.2016.02.018 Steiner, 2020, Innate immune cells and C-reactive protein in acute first-episode psychosis and schizophrenia: relationship to psychopathology and treatment, Schizophr. Bull., 46, 363 Störchel, 2015, A large-scale functional screen identifies Nova1 and Ncoa3 as regulators of neuronal miRNA function, EMBO J., 34, 2237, 10.15252/embj.201490643 Su, 2022, Identification of altered exosomal microRNAs and mRNAs in Alzheimer’s disease, Ageing Res Rev., 73, 10.1016/j.arr.2021.101497 Sumiyoshi, 2001, The effect of tandospirone, a serotonin(1A) agonist, on memory function in schizophrenia, Biol. Psychiatry, 49, 861, 10.1016/S0006-3223(00)01025-8 Sumiyoshi, 2008, Serotonin1A receptors in the pathophysiology of schizophrenia: development of novel cognition-enhancing therapeutics, Adv. Ther., 25, 1037, 10.1007/s12325-008-0102-2 Sun, 2015, MicroRNAs: Small molecules with big roles in neurodevelopment and diseases, Exp. Neurol., 268, 46, 10.1016/j.expneurol.2014.08.005 Sun, 2015, Aberrant microRNA expression in peripheral plasma and mononuclear cells as specific blood-based biomarkers in schizophrenia patients, 22, 570 Sun, 2015, A preliminary analysis of microRNA as potential clinical biomarker for schizophrenia, Am. J. Med Genet B Neuropsychiatr. Genet, 168B, 170, 10.1002/ajmg.b.32292 Tao, 2018, GAD1 alternative transcripts and DNA methylation in human prefrontal cortex and hippocampus in brain development, schizophrenia, Mol. Psychiatry, 23, 1496, 10.1038/mp.2017.105 Thaker, 2001, Advances in schizophrenia, Nat. Med, 7, 667, 10.1038/89040 Thomas, 2017, Inhibition of the schizophrenia-associated MicroRNA miR-137 disrupts Nrg1α neurodevelopmental signal transduction, Cell Rep., 20, 1, 10.1016/j.celrep.2017.06.038 Thomas, 2018, microRNAs sculpt neuronal communication in a tight balance that is lost in neurological disease, Front Mol. Neurosci., 11, 455, 10.3389/fnmol.2018.00455 Tosic, 2006, Schizophrenia and oxidative stress: glutamate cysteine ligase modifier as a susceptibility gene, Am. J. Hum. Genet., 79, 586, 10.1086/507566 Trépanier, 2016, Postmortem evidence of cerebral inflammation in schizophrenia: a systematic review, Mol. Psychiatry, 21, 1009, 10.1038/mp.2016.90 Tsoporis, 2022, A longitudinal study of alterations of circulating DJ-1 and miR203a-3p in association to olanzapine medication in a sample of first episode patients with schizophrenia, J. Psychiatr. Res, 146, 109, 10.1016/j.jpsychires.2021.12.049 Tung, 2021, The regulatory roles of microRNAs toward pathogenesis and treatments in Huntington’s disease, J. Biomed. Sci., 28, 59, 10.1186/s12929-021-00755-1 Uzuneser, 2019, Disrupted-in-Schizophrenia 1 (DISC1) Overexpression and Juvenile Immune Activation Cause Sex-Specific Schizophrenia-Related Psychopathology in Rats, Front Psychiatry, 10, 222, 10.3389/fpsyt.2019.00222 Vink, 2016, DRD2 Schizophrenia-Risk Allele Is Associated With Impaired Striatal Functioning in Unaffected Siblings of Schizophrenia Patients, Schizophr. Bull., 42, 843, 10.1093/schbul/sbv166 Vishnoi, 2017, MiRNA biogenesis and regulation of diseases: an overview, Methods Mol. Biol., 1509, 1, 10.1007/978-1-4939-6524-3_1 Volpicelli, 2019, The microRNA-29a Modulates Serotonin 5-HT7 Receptor Expression and Its Effects on Hippocampal Neuronal Morphology, Mol. Neurobiol., 56, 8617, 10.1007/s12035-019-01690-x Vos, 2017, Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016, Lancet, 390, 1211, 10.1016/S0140-6736(17)32154-2 Walker, 2015, Preliminary investigation of miRNA expression in individuals at high familial risk of bipolar disorder, J. Psychiatr. Res, 62, 48, 10.1016/j.jpsychires.2015.01.006 Wang, 2009, Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia, Bipolar Disord., 11, 523, 10.1111/j.1399-5618.2009.00717.x Wang, 2021, A Microfluidics-Based Scalable Approach to Generate Extracellular Vesicles with Enhanced Therapeutic MicroRNA Loading for Intranasal Delivery to Mouse Glioblastomas, ACS Nano, 15, 18327, 10.1021/acsnano.1c07587 Wang, 2019, A Natural Product with High Affinity to Sigma and 5-HT7 Receptors as Novel Therapeutic Drug for Negative and Cognitive Symptoms of Schizophrenia, Neurochem Res, 44, 2536, 10.1007/s11064-019-02873-7 Wang, 2021, Mir-139-5p inhibits glioma cell proliferation and progression by targeting GABRA1, J. Transl. Med, 19, 213, 10.1186/s12967-021-02880-9 Wang, 2019, D2 receptor-mediated miRNA-143 expression is associated with the effects of antipsychotic drugs on phencyclidine-induced schizophrenia-related locomotor hyperactivity and with Neuregulin-1 expression in mice, Neuropharmacology, 157, 10.1016/j.neuropharm.2019.107675 Wang, 2021, TPN672: A Novel Serotonin-Dopamine Receptor Modulator for the Treatment of Schizophrenia, J. Pharm. Exp. Ther., 378, 20, 10.1124/jpet.120.000414 Wang, 2011, DJ-1 modulates the expression of Cu/Zn-superoxide dismutase-1 through the Erk1/2-Elk1 pathway in neuroprotection, Ann. Neurol., 70, 591, 10.1002/ana.22514 Wei, 2020, Interaction of oxidative stress and BDNF on executive dysfunction in patients with chronic schizophrenia, Psychoneuroendocrinology, 111, 10.1016/j.psyneuen.2019.104473 Wei, 2015, Detection of circulating miRNA levels in schizophrenia, Am. J. Psychiatry, 172, 1141, 10.1176/appi.ajp.2015.14030273 Wei, 2020, Exosomes from patients with major depression cause depressive-like behaviors in mice with involvement of miR-139-5p-regulated neurogenesis, Neuropsychopharmacology, 45, 1050, 10.1038/s41386-020-0622-2 Weickert, 2013, Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia, Mol. Psychiatry, 18, 1185, 10.1038/mp.2012.137 Weickert, 2019, Increased plasma Brain-Derived Neurotrophic Factor (BDNF) levels in females with schizophrenia, Schizophr. Res, 209, 212, 10.1016/j.schres.2019.04.015 Weinstein, 2018, PET imaging of dopamine-D2 receptor internalization in schizophrenia, Mol. Psychiatry, 23, 1506, 10.1038/mp.2017.107 Williams, 2022, Inflammation and Brain Structure in Schizophrenia and Other Neuropsychiatric Disorders: A Mendelian Randomization Study, JAMA Psychiatry, 79, 498, 10.1001/jamapsychiatry.2022.0407 Wong, 2013, Expression of NPAS3 in the human cortex and evidence of its posttranscriptional regulation by miR-17 during development, with implications for schizophrenia, Schizophr. Bull., 39, 396, 10.1093/schbul/sbr177 Woo, 2020, The complement system in schizophrenia: where are we now and what’s next?, Mol. Psychiatry, 25, 114, 10.1038/s41380-019-0479-0 Wu, 2020, MicroRNA-15a, microRNA-15b and microRNA-16 inhibit the human dopamine D1 receptor expression in four cell lines by targeting 3’UTR -12 bp to + 154 bp, Artif. Cells Nanomed. Biotechnol., 48, 276, 10.1080/21691401.2019.1703729 Xin, 2016, Genetic Polymorphism Associated Prefrontal Glutathione and Its Coupling With Brain Glutamate and Peripheral Redox Status in Early Psychosis, Schizophr. Bull., 42, 1185, 10.1093/schbul/sbw038 Xu, 2018, GABAergic inhibitory neurons as therapeutic targets for cognitive impairment in schizophrenia, Acta Pharm. Sin., 39, 733, 10.1038/aps.2017.172 Xu, 2010, MicroRNAs and target site screening reveals a pre-microRNA-30e variant associated with schizophrenia, Schizophr. Res, 119, 219, 10.1016/j.schres.2010.02.1070 Xu, 2016, Exploring Transcription Factors-microRNAs Co-regulation Networks in Schizophrenia, Schizophr. Bull., 42, 1037, 10.1093/schbul/sbv170 Yamazaki, 2018, Functional mechanism of ASP5736, a selective serotonin 5-HT5A receptor antagonist with potential utility for the treatment of cognitive dysfunction in schizophrenia, Eur. Neuropsychopharmacol., 28, 620, 10.1016/j.euroneuro.2018.03.003 Yan, 2018, Neuregulin-2 ablation results in dopamine dysregulation and severe behavioral phenotypes relevant to psychiatric disorders, Mol. Psychiatry, 23, 1233, 10.1038/mp.2017.22 Yang, 2017, Altered expression of BDNF, BDNF pro-peptide and their precursor proBDNF in brain and liver tissues from psychiatric disorders: rethinking the brain-liver axis, Transl. Psychiatry, 7, 10.1038/tp.2017.95 Yang, 2019, Sex difference in the association of body mass index and BDNF levels in Chinese patients with chronic schizophrenia, Psychopharmacol. (Berl. ), 236, 753, 10.1007/s00213-018-5107-1 Yang, 2017, Delivery of Small Interfering RNA to Inhibit Vascular Endothelial Growth Factor in Zebrafish Using Natural Brain Endothelia Cell-Secreted Exosome Nanovesicles for the Treatment of Brain Cancer, AAPS J., 19, 475, 10.1208/s12248-016-0015-y Yang, 2022, A functional SNP rs895819 on pre-miR-27a is associated with bipolar disorder by targeting NCAM1, Commun. Biol., 5, 309, 10.1038/s42003-022-03263-6 Yao, 2004, Increased nitric oxide radicals in postmortem brain from patients with schizophrenia, Schizophr. Bull., 30, 923, 10.1093/oxfordjournals.schbul.a007142 Yasuno, 2004, Decreased 5-HT1A receptor binding in amygdala of schizophrenia, Biol. Psychiatry, 55, 439, 10.1016/j.biopsych.2003.11.016 Yoon, 2014, Task-evoked substantia nigra hyperactivity associated with prefrontal hypofunction, prefrontonigral disconnectivity and nigrostriatal connectivity predicting psychosis severity in medication naïve first episode schizophrenia, Schizophr. Res, 159, 521, 10.1016/j.schres.2014.09.022 Yoshikawa, 2021, Dysregulation of post-transcriptional modification by copy number variable microRNAs in schizophrenia with enhanced glycation stress, Transl. Psychiatry, 11, 331, 10.1038/s41398-021-01460-1 Yu, 2015, Alterations of miR-132 are novel diagnostic biomarkers in peripheral blood of schizophrenia patients, Prog. Neuropsychopharmacol. Biol. Psychiatry, 63, 23, 10.1016/j.pnpbp.2015.05.007 Yu, 2018, Rare loss of function mutations in N-methyl-D-aspartate glutamate receptors and their contributions to schizophrenia susceptibility, Transl. Psychiatry, 8, 12, 10.1038/s41398-017-0061-y Zajdel, 2021, Structure-Based Design and Optimization of FPPQ, a Dual-Acting 5-HT3 and 5-HT6 Receptor Antagonist with Antipsychotic and Procognitive Properties, J. Med Chem., 64, 13279, 10.1021/acs.jmedchem.1c00224 Zakzanis, 1998, Dopamine D2 densities and the schizophrenic brain, Schizophr. Res, 32, 201, 10.1016/S0920-9964(98)00041-3 Zhang, 2015, The role of serotonin 5-HT2A receptors in memory and cognition, Front Pharm., 6, 225, 10.3389/fphar.2015.00225 Zhang, 2021, Integrated analysis of the chemical-material basis and molecular mechanisms for the classic herbal formula of Lily Bulb and Rehmannia Decoction in alleviating depression, Chin. Med, 16, 107, 10.1186/s13020-021-00519-x Zhang, 2015, Association of a Schizophrenia Risk Variant at the DRD2 Locus With Antipsychotic Treatment Response in First-Episode Psychosis, Schizophr. Bull., 41, 1248, 10.1093/schbul/sbv116 Zhang, 2016, Cortical grey matter volume reduction in people with schizophrenia is associated with neuro-inflammation, Transl. Psychiatry, 6, 10.1038/tp.2016.238 Zhao, 2019, Effect of Electroacupuncture on Reuptake of Serotonin via miRNA-16 Expression in a Rat Model of Depression, Evid. Based Complement Altern. Med, 2019, 7124318, 10.1155/2019/7124318 Zhao, 2007, Systematic study of association of four GABAergic genes: glutamic acid decarboxylase 1 gene, glutamic acid decarboxylase 2 gene, GABA(B) receptor 1 gene and GABA(A) receptor subunit beta2 gene, with schizophrenia using a universal DNA microarray, Schizophr. Res, 93, 374, 10.1016/j.schres.2007.02.023 Zhao, 2019, Altered expression of microRNA-223 in the plasma of patients with first-episode schizophrenia and its possible relation to neuronal migration-related genes, Transl. Psychiatry, 9, 289, 10.1038/s41398-019-0609-0 Zhou, 2018, Antibody modified nanoparticle-mediated delivery of miR-124 regulates apoptosis via repression the Stat3 signal in mycobacterial-infected microglia, J. Biomed. Nanotechnol., 14, 2185, 10.1166/jbn.2018.2650 Zhu, 2009, A MicroRNA gene is hosted in an intron of a schizophrenia-susceptibility gene, Schizophr. Res, 109, 86, 10.1016/j.schres.2009.01.022 Zurawek, 2019, Resilient Phenotype in Chronic Mild Stress Paradigm Is Associated with Altered Expression Levels of miR-18a-5p and Serotonin 5-HT1a Receptor in Dorsal Part of the Hippocampus, Mol. Neurobiol., 56, 7680, 10.1007/s12035-019-1622-2